Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD

Diabetologia

Volumn 58, Issue 6, 2015, Pages 1160-1166

  Chow, Lisa S ^a,b,c   Chen, Haiying ^a,b,c   Miller, Michael E ^a,b,c   Marcovina, Santica M ^a,b,c   Seaquist, Elizabeth R ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ACCORD study; Insulin deficiency; Islet autoantibodies

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; C PEPTIDE; CATION TRANSPORT PROTEIN; GLUTAMATE DECARBOXYLASE; INSULIN; PTPRN PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; SLC30A8 PROTEIN, HUMAN;

AGED; BLOOD; BODY MASS; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CHEMISTRY; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; IMMUNOLOGY; MALE; MICROCIRCULATION; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; RANDOMIZED CONTROLLED TRIAL;

AGED; AUTOANTIBODIES; BIOMARKERS; BODY MASS INDEX; C-PEPTIDE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; HYPOGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; MALE; MICROCIRCULATION; MIDDLE AGED; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;

EID: 84939969999     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3512-0     Document Type: Article

References (31)

1. Bonds DE, Kurashige EM, Bergenstal R et al (2007) Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Am J Cardiol 99:S80–S89
2. Leese GP, Wang J, Broomhall J et al (2003) Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26:1176–1180
3. Zoungas S, Patel A, Chalmers J et al (2010) Severe hypoglycemia and risks of vascular events and death. N Engl J Med 363:1410–1418
4. Turnbull FM, Abraira C, Anderson RJ et al (2009) Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52:2288–2298
5. Miller ME, Bonds DE, Gerstein HC et al (2010) The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340:b5444
6. 1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging study. Diabetes Care 36:3535–3542
7. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA (2012) Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 35:1897–1901
8. Siegelaar SE, Holleman F, Hoekstra JBL, DeVries JH (2010) Glucose variability; does it matter? Endocr Rev 31:171–182
9. Buse JB, Bigger JT, Byington RP et al (2007) Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 99:21i–33i
10. Bergstralh EJ, Kosanke J. (2003) Locally written SAS macros. Available from www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sas-macros. Accessed July 2014
11. Bergstralh EJ, Kosanke J. (2014) Locally written SAS macros. Available from www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sas-macros. Accessed July 2014
12. Bergstralh EJ, Kosanke JL, Jacobsen SJ (1996) Software for optimal matching in observational studies. Epidemiol (Camb Mass) 7:331–332
13. Berger B, Stenstrom G, Sundkvist G (2000) Random C-peptide in the classification of diabetes. Scand J Clin Lab Investig 60:687–693
14. Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30:803–817
15. Bonifacio E, Yu L, Williams AK et al (2010) Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia. J Clin Endocrinol Metab 95:3360–3367
16. Schernthaner G (1993) Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 16:155–165
17. Bonds DE, Miller ME, Bergenstal RM et al (2010) The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340:b4909
18. Alsahli M, Gerich JE (2013) Hypoglycemia. Endocrinol Metab Clin N Am 42:657–676
19. Amiel SA, Dixon T, Mann R, Jameson K (2008) Hypoglycaemia in type 2 diabetes. Diabet Med 25:245–254
20. 1c. BMC Endocr Disord 13:59
21. Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G (1993) Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16:902–910
22. Group UHS (2007) Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50:1140–1147
23. Irvine WJ, Gray RS, McCallum CJ, Duncan LJP (1977) Clinical and pathogenic significance of pancreatic–islet-cell antibodies in diabetics treated with oral hypoglycaemic agents. Lancet 1:1025–1027
24. Hawa MI, Buchan AP, Ola T et al (2014) LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes. Diabetes Care 37:1643–1649
25. Zimmet PZ (1995) The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care 18:1050–1064
26. Fourlanos S, Dotta F, Greenbaum CJ et al (2005) Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206–2212
27. Cryer PE (2004) Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272–2279
28. Cryer PE, Davis SN, Shamoon H (2003) Hypoglycemia in diabetes. Diabetes Care 26:1902–1912
29. Segel SA, Paramore DS, Cryer PE (2002) Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724–733
30. Kirkman MS, Briscoe VJ, Clark N et al (2012) Diabetes in older adults. Diabetes Care 35:2650–2664
31. Chow LS CH, Miller M, Marcovina S, Seaquist E (2014) Biomarkers associated with severe hypoglycemia and failure to achieve good glycemic control in T2DM: the ACCORD study. Diabetes 63(Suppl1):A45, Abstract